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Abstract
There is heterogeneity in invariant natural killer T (iNKT) cells based on the expression of CD4 and the IL-17 receptor B (IL-
17RB), a receptor for IL-25 which is a key factor in TH2 immunity. However, the development pathway and precise function
of these iNKT cell subtypes remain unknown. IL-17RB
+ iNKT cells are present in the thymic CD44
+/2 NK1.1
2 population and
develop normally even in the absence of IL-15, which is required for maturation and homeostasis of IL-17RB
2 iNKT cells
producing IFN-c. These results suggest that iNKT cells contain at least two subtypes, IL-17RB
+ and IL-17RB
2 subsets. The IL-
17RB
+ iNKT subtypes can be further divided into two subtypes on the basis of CD4 expression both in the thymus and in the
periphery. CD4
+ IL-17RB
+ iNKT cells produce TH2 (IL-13), TH9 (IL-9 and IL-10), and TH17 (IL-17A and IL-22) cytokines in
response to IL-25 in an E4BP4-dependent fashion, whereas CD4
2 IL-17RB
+ iNKT cells are a retinoic acid receptor-related
orphan receptor (ROR)ct
+ subset producing TH17 cytokines upon stimulation with IL-23 in an E4BP4-independent fashion.
These IL-17RB
+ iNKT cell subtypes are abundantly present in the lung in the steady state and mediate the pathogenesis in
virus-induced airway hyperreactivity (AHR). In this study we demonstrated that the IL-17RB
+ iNKT cell subsets develop
distinct from classical iNKT cell developmental stages in the thymus and play important roles in the pathogenesis of airway
diseases.
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Introduction
Natural killer T (NKT) cells, unlike conventional T cells bearing
diverse antigen receptors, are characterized by the expression of
an invariant T cell receptor (TCR), Va14Ja18 paired with Vb8,
Vb7, or Vb2 in mice [1] and the Va24Ja18/Vb11 pair in humans
[2,3], that recognizes glycolipid antigens in conjunction with the
monomorphic MHC class I-like CD1d molecule [4,5]. Therefore,
these cells are termed invariant NKT (iNKT) cells. Another
characteristic feature of iNKT cells is their rapid and massive
production of a range of cytokines, such as those typically
produced by T helper cell (TH)1 ,T H2, and TH17 cells [6–8],
upon stimulation with their ligand, a-Galactosylceramide (a-
GalCer) [9,10].
It is speculated that the ability of iNKT cells to produce these
various cytokines is due either to the microenvironment in which
they undergo priming or to the existence of functionally distinct
subtypes of iNKT cells producing different cytokines; however,
there is no clear-cut evidence to support the latter notion. It has
been reported that iNKT cells include both CD4
+ and CD4
2
subtypes [6,11], each of which produces different cytokines.
Human CD4
+ iNKT cells produce both TH1 and TH2 cytokines,
whereas CD4
2 iNKT cells produce mainly TH1 cytokines [12,13].
Although such functional differences were originally less apparent
in mouse CD4
+ and CD4
2 iNKT cells, two functionally distinct
subtypes of iNKT cells in the mouse thymus have since been
identified based on NK1.1 expression; NK1.1
2 iNKT cells
produce a large amount of IL-4 and little IFN-c, whereas
NK1.1
+ iNKT cells produce less IL-4 and more IFN-c [14,15].
Furthermore, CD4
2 iNKT cells in the liver have been found to be
more effective in mediating tumor rejection than CD4
+ iNKT cells
in the liver or any other tissues [16].
There is also further heterogeneity of CD4
+ iNKT cells in terms
of expression of the IL-17 receptor B (IL-17RB), a receptor for IL-
25 [17]. IL-25 is a key factor in TH2 immunity, including allergic
reactions and airway hyperreactivity (AHR). The CD4
+ IL-17RB
+
iNKT cells produce large amounts of IL-13 and IL-4 but little
IFN-c in response to IL-25, mediating a key role in IL-25-driven
PLoS Biology | www.plosbiology.org 1 February 2012 | Volume 10 | Issue 2 | e1001255AHR [17,18]. Another subset of newly identified iNKT cells
within the NK1.1
2 CD4
2 subset is the retinoic acid receptor-
related orphan receptor (ROR)ct
+ iNKT cells. These cells can
induce autoimmune disorders by their production of IL-17A and
IL-22 [8,19], even though IL-17A-producing iNKT cells are not
restricted to a particular iNKT cell subset [20].
The emergence of functionally distinct subpopulations of iNKT
cells is reminiscent of how iNKT subtypes develop in the thymus
and expand in the periphery. Here, we demonstrate IL-17RB
+
iNKT cells are a subtype distinct from the CD122
+ iNKT cells
producing IFN-c. Moreover, there are two subtypes of IL-17RB
+
iNKT cells; CD4
2 produces TH17 cytokines in an IL-23-
dependent fashion, whereas the other CD4
+ produces TH2 and
TH17 cytokines in an IL-25 dependent manner. In addition, these
IL-17RB
+ iNKT cells contribute to the induction of virus and viral
antigen-induced chronic AHR.
Results
Identification of Two Distinct Subtypes in iNKT Cells; IL-
17RB
+ iNKT Cells Producing TH2 and TH17 Cytokines and
IL-17RB
2 iNKT Cells Producing IFN-c
We previously identified a fraction of splenic CD4
+ iNKT cells
that expresses IL-17RB and produces TH2 cytokines after
treatment with IL-25 [17]. In order to directly analyze the
function of IL-17RB on iNKT cells, we generated IL-17RB-
deficient mice by the disruption of exon 1 and exon 2 of the Il17rb
gene (Figure S1). We then compared the number and function of
iNKT cells in the spleen and the liver from Il17rb
2/2 mice on a
C57BL/6 (B6) background to those of wild type (WT) B6 mice.
We also included in our comparison Il15
L117P mice, in which
leucine (CTT) at amino acid position 117 of IL-15 was substituted
with proline (CCT), because IL-15 is reported to be critical for the
development and homeostatic maintenance of iNKT cells [21,22],
as well as other cell types such as NK and CD8
+ memory T cells
[23,24]. As shown in Figure 1A, the number of iNKT cells in
Il17rb
2/2 mice was only slightly decreased in the spleen, and was
almost comparable in the liver, compared with B6 mice, findings
consistent with our previous analysis on the distribution of IL-
17RB
+ iNKT cells (3%–5% in the spleen and almost none in the
liver) as detected by a specific monoclonal antibody [17].
Similarly, Il15
L117P mice appear to recapitulate the previously
reported phenotype of Il15
2/2 mice [21,22] because iNKT and
NK cells were decreased by 50% in the spleen and by 90% in the
liver, indicating that the L117P mutation resulted in the loss of IL-
15 function.
We then analyzed the frequency of IL-17RB
+ subtypes among
a-GalCer/CD1d dimer
+ iNKT cells in the spleen and liver of WT,
Il17rb
2/2, and Il15
L117P mice (Figure 1B). The percentage of IL-
17RB
+ iNKT cells was increased more than 4 times in the spleen
and 10 times in liver of the Il15
L117P mice.
By using Il17rb
2/2 and Il15
L117P mice, we further analyzed the
iNKT cell subtypes in terms of their ability to produce cytokines
(Figure 1C and 1D). a-GalCer/CD1d dimer
+ TCRb
+ iNKT cells
from the spleen of WT, Il17rb
2/2, and Il15
L117P mice (Figure 1C)
and those from the liver of B6 and Il17rb
2/2 mice (Figure 1D)
were sorted and co-cultured with GM-CSF-induced bone marrow
derived dendritic cells (BM-DCs) in the presence of a-GalCer. The
Il17rb
2/2 iNKT cells produced normal levels of IFN-c, but this
was significantly decreased in Il15
L117P iNKT cells. Intriguingly,
there was impaired production of not only TH2 cytokines such as
IL-9, IL-10, and IL-13, but also of TH17 cytokines IL-17A and IL-
22 in Il17rb
2/2 iNKT cells, but not in Il15
L117P iNKT cells in the
spleen (Figure 1C and 1D), even though the number of iNKT cells
were only slightly decreased in Il17rb
2/2 (see Figure 1A). The
iNKT cells derived from WT, Il17rb
2/2,o rIl15
L117P failed to
produce any indicated cytokines when co-cultured with BM-DCs
from Cd1d1
2/2 mice (unpublished data), indicating the cytokine
production from iNKT cells are absolutely CD1d/a-GalCer
dependent.
To examine the functional activity of Il17rb
2/2 iNKT cells in
vivo, we administered a-GalCer (2 mg) intravenously (i.v.) and
monitored serum cytokine levels (Figure 1E). The production of
IFN-c peaked normally at 12 to 24 h after stimulation in the
Il17rb
2/2 mice. On the other hand, the production (around 1–
6 h) of other cytokines, such as IL-9, IL-10, IL-13, IL-17A, and IL-
22, was severely impaired in the Il17rb
2/2 mice. The results
suggest that IL-17RB
+ iNKT cells are distinct from IL-17RB
2
iNKT cells, which mainly produce IFN-c, and also that IL-17RB
+
iNKT cells produce IL-9, IL-10, and IL-13 among TH2 cytokines
and IL-17A and IL-22 TH17-type cytokines.
Development of IL-17RB
+ and IL-17RB
2 iNKT Subtypes in
the Thymus
iNKT cells in the spleen and liver from il17rb
2/2 mice are
defective in the production of IL-9, IL-10, IL-13, IL-17A, and IL-
22, while IFN-c production is diminished in Il15
L117P iNKT cells
(Figure 1). We therefore attempted to identify the origin of IL-
17RB
+ iNKT cells in the thymus by comparing a-GalCer/CD1d
dimer
+ iNKT cells in B6 with those in Il17rb
2/2 and in Il15
L117P
mice on a B6 background (Figure 2A). The percentage and
number of iNKT cells in the thymus were severely decreased in
Il15
L117P mice to a similar extent as previously reported in Il15
2/2
mice [21]. By contrast, the percentage and number of iNKT cells
in Il17rb
2/2 mice was only slightly decreased, to a similar extent to
Author Summary
T cells are a diverse group of immune cells involved in cell-
mediated acquired immunity. One subset of T cells is the
innate-like invariant natural killer T (iNKT) cells that
recognize glycolipid ligands on target cells instead of
peptides. We know that functionally distinct subtypes of
iNKT cells are involved in specific pathologies, yet their
development, phenotypes, and functions are not well
understood. Here, we determine the relationship between
various mouse iNKT cell subsets, identify reliable molecular
markers for these subsets, and show that these contribute
to their functional differences. We identify four iNKT cell
subsets that we show arise via different developmental
pathways and exhibit different cytokine profiles. Impor-
tantly, we show that these subsets can be isolated from
the thymus (the organ of all T cells), as well as from
peripheral tissues such as spleen, liver, lung, and lymph
nodes. Contrary to the general understanding that iNKT
cells mature after their exit from the thymus and their
migration into peripheral tissues, we conclude that distinct
phenotypic and functional iNKT cell subsets can be
distinguished in the thymus by virtue of the presence or
absence of the cytokine receptor IL-17RB and another cell
surface molecule called CD4, and these subsets then
migrate to peripheral tissues where they retain their
phenotypic and functional characteristics. Regarding
functional significance, we show that those iNKT cell
subsets that lead to airway hyper-responsiveness to
respiratory viruses are different to those that lead to
allergen-induced airway hyperreactivity, which will enable
researchers to focus on specific subsets as potential
targets for therapeutic intervention.
TH2- and TH17-Cytokine-Producing iNKT Cells
PLoS Biology | www.plosbiology.org 2 February 2012 | Volume 10 | Issue 2 | e1001255Figure 1. Function of iNKT cells in the spleen and liver from Il17rb
2/2 and Il15
L117P mice. (A) FACS profile of spleen and liver mononuclear
cells in WT, Il17rb
2/2 and Il15
L117P mice on a B6 background. Numbers are percentage of gated cells. a-GalCer/CD1d dimer
+ iNKT cells and a-GalCer/
CD1d dimer
2 NK1.1
+ NK cells were slightly decreased in Il17rb
2/2 mice and markedly reduced in Il15
L117P mice. (B) IL-17RB expression in spleen and
liver iNKT cells of WT B6, Il17rb
2/2 and Il15
L117P mice. Shaded profiles in the histograms indicate the background staining with isotype matched
control mAb. (C, D) In vitro cytokine production by spleen iNKT cells from Il17rb
2/2 and Il15
L117P mice (C) and by liver iNKT cells from Il17rb
2/2 mice
(D). Sorted iNKT cells (5610
4/100 mL) from spleen and liver of WT B6 and Il17rb
2/2 mice were co-cultured with BM-DCs (5610
3/100 mL) for 48 h in the
presence of the indicated doses of a-GalCer. The Il17rb
2/2 iNKT cells produced IFN-c at levels equivalent to WT, while TH2 and TH17 cytokine
production, except for IL-4, were severely impaired. (E) iNKT cell-dependent cytokine production in WT B6 and Il17rb
2/2 mice in vivo. a-GalCer (2 mg)
was i.v. injected and the levels of cytokines in serum were analyzed at the indicated time points. The serum IFN-c levels were similar in both mice,
whereas production of TH2 and TH17 cytokines, except for IL-4, was significantly reduced in the Il17rb
2/2 mice. Cytokines were measured by ELISA or
a cytometric bead array system at the indicated time points. Data are mean 6 SDs from three mice and repeated three times with similar results.
doi:10.1371/journal.pbio.1001255.g001
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analyze their phenotype precisely, enriched a-GalCer/CD1d
dimer
+ iNKT cells were further divided based on the expression
of CD44 and NK1.1 (Figure 2B), because iNKT cells can be
classified into developmental stages based on the cell surface
expression of these molecules, i.e., CD44
lo NK1.1
2 (Stage 1),
CD44
hi NK1.1
2 (Stage 2), and CD44
hi NK1.1
+ (Stage 3) [14,25].
In agreement with earlier results [21], there was a decrease in the
CD44
hi NK1.1
+ (Stage 3) population of a-GalCer/CD1d dimer
+
iNKT cells in the thymus of Il15
L117P mice. By contrast, the
percentage and number of iNKT cells in Il17rb
2/2 mice were
reduced, especially in the CD44
lo NK1.1
2 (Stage 1) and CD44
hi
NK1.1
2 (Stage 2) populations, although the CD44
hi NK1.1
+
(Stage 3) population was unchanged (Figure 2B). To determine
whether the reduction in absolute numbers of developmental
Stages 1 and 2 iNKT cell populations in Il17rb
2/2 mice is due to a
developmental defect or to bypassing of these developmental
stages, we analyzed surface expression of IL-17RB and CD122, a
receptor for IL-15 (Figure 2C). Consistent with the observation
shown in Figure 2B, IL-17RB expression was detected mainly in
the Stage 1 and Stage 2 populations in both CD4
2 and CD4
+
fractions (Figure 2C), whereas CD122 expression was mainly in
the Stage 3 population as previously reported [21], and is inversely
correlated with the expression of IL-17RB (Figure 2C). In order to
investigate whether IL-17RB
+ iNKT cells are distinct from IL-15-
dependent iNKT cells, thymic iNKT cells from B6 and Il15
L117P
mice were divided based on the expression of IL-17RB and CD4,
and were further analyzed in the expression of CD44 and NK1.1
(Figure 2D and 2E). The percentage of CD4
2 and CD4
+, IL-
17RB
+ iNKT cells was higher in Il15
L117P mice (Figure 2D), due
to the reduction in the numbers of IL-17RB
2 iNKT cells.
Concerning the distribution of the expression of CD44 and NK1.1
in iNKT cell subtypes, even though IL-17RB
+ iNKT cells
comprised only ,10% of the thymic iNKT cells, more than half
of them were Stage 2, while almost all (.97%) of the CD4
2 and
CD4
+, IL-17RB
2 iNKT cells were Stage 3 (Figure 2E). Further-
more, more than 80% of Stage 1/2 iNKT cells were IL-17RB
+
iNKT cells, while only ,2% of the Stage 3 iNKT cells were IL-
17RB
+ (Figure 2D). The percentage (Figure 2F) and absolute
number (Figure 2G) of IL-17RB
+ iNKT cells among the total
iNKT cells and in developmental Stages 1 and 2 were similar to
those of Il15
L117P mice, while those of IL-17RB
2 iNKT cells (i.e.,
CD122
+ iNKT cells) among the total and in developmental Stage
3 were also comparable to those in Il17rb
2/2 mice, indicating that
two distinct iNKT cell subsets are present in the different stages of
iNKT cell development, i.e., the IL-17RB
+ subtype in Stages 1
and 2 and the CD122
+ subtype in Stage 3.
In order to determine if iNKT cell subtypes arise as a distinct
population in the thymus of each other, each subtype in Stage 1 or
Stage 2 was sorted and co-cultured with a fetal thymus (FT) lobe
from Ja18
2/2 mice (Figure 2H and 2I). IL-17RB
2 subtype in
Stage 1 gave rise to cells in Stage 2 and Stage 3 with IL-17RB
2
phenotype (Figure 2H and 2I, lower left), whereas IL-17RB
+
subtype in Stage 1 gave rise to cells in Stage 2 but not to Stage 3
with IL-17RB
+ phenotype (Figure 2H and 2I, upper left).
Furthermore, IL-17RB
2 subtype in Stage 2 gave rise to cells in
Stage 3 with IL-17RB
2 phenotype (Figure 2H and 2I, lower left),
whereas IL-17RB
+ subtype in Stage 2 kept in Stage 2 with IL-
17RB
+ phenotype (Figure 2H and 2I, upper left), indicating that
IL-17RB
+ iNKT cells arise in the thymus as distinct phenotypic
subtypes from IL-17RB
2 iNKT cells, which undergo a series of
developmental stages (i.e. Stages 1–3) previously characterized
[14,15].
To confirm the differences among subtypes of iNKT cells, we
compared global gene expression profiles in WT B6 CD4
2 or
CD4
+, IL-17RB
+ or IL-17RB
2, iNKT cells to each other (Figure
S2A), and also WT B6 CD4
2 or CD4
+, IL-17RB
+ iNKT cells to
the same cell types from Il15
L117P mice (Figure S2B). The genome-
wide expression profile of the CD4
2 and CD4
+, IL-17RB
+ iNKT
cells were similar to each other but different from those of CD4
2
and CD4
+, IL-17RB
2 iNKT cells (Figure S2A). Moreover, the
gene expression profiles of CD4
2 or CD4
+, IL-17RB
+ WT iNKT
cells were similar to those in Il15
L117P mice (Figure S2B).
Therefore, it is likely that IL-17RB
+ iNKT cell development in
the thymus is distinct from the IL-17RB
2 (i.e. CD122
+) iNKT
cells. The gene expression profiles of the CD4
+ IL-17RB
+ iNKT
cells were quite similar to those of the CD4
2 IL-17RB
+ cells rather
than the CD4
2 or CD4
+, IL-17RB
2 iNKT cells (Figure S2A),
suggesting that these two subtypes, CD4
2 and CD4
+, IL-17RB
+
iNKT cells, develop from the same precursors, whereas the
precursors for IL-17RB
2 iNKT cells are distinct.
In order to investigate functional differences in the IL-17RB
+
and IL-17RB
2 subsets of iNKT cells, we analyzed the ability of
thymic iNKT cells in B6, Il17rb
2/2 and Il15
L117P mice to produce
cytokines in response to a-GalCer (Figure S3). IFN-c was
produced at similar levels by Il17rb
2/2 and WT iNKT cells, but
was greatly reduced in the Il15
L117P iNKT cells, while the
production of IL-9, IL-10, IL-13, IL-17A, and IL-22 was impaired
in the Il17rb
2/2 but not in the Il15
L117P iNKT cells, similar to
what we had observed in the spleen and liver (Figure S3).
Dominant Development of IL-17RB
+ iNKT Subtypes in
TH2-Prone BALB/c Mice
In a previous study, IL-17RB
+ iNKT cells were fairly abundant
in the spleen of TH2-prone mice, but were barely detectable in
TH1-prone mice [17]. Thus, we examined whether the frequency
of IL-17RB
+ iNKT cells in the thymus of BALB/c mice is different
from that of B6 mice. Intriguingly, more than one-third of thymic
iNKT cells were IL-17RB
+ in TH2-prone BALB/c mice, four
times higher than in TH1-prone B6 mice (Figure S4A). The
genome-wide expression profiles of CD4
2 or CD4
+, IL-17RB
+
iNKT cells in BALB/c were similar to each other, but different
from those of CD4
2 or CD4
+, IL-17RB
2 iNKT cells (Figure S4B).
Cluster analysis also showed that CD4
2 or CD4
+, IL-17RB
+ or
IL-17RB
2 iNKT cells in B6 and BALB/c mice were essentially
equivalent (Figure S4C).
Genetic Analysis of iNKT Cell Subtypes in the Thymus
iNKT cells in the thymus can be divided into four populations
based on their expression of CD4 and IL-17RB (Figures 2D and
S4A), and thymic Il17rb
2/2 iNKT cells had a decreased ability to
produce TH2 and TH17 cytokines (Figure S3). Therefore, we
analyzed the function of iNKT cell subtypes in the thymus of B6
(Figure 3) and BALB/c mice (Figure S5). We first used quantitative
real-time PCR to investigate TH1/TH2/TH17-related gene
expression patterns in FACS sorted thymic iNKT subtypes. The
levels of Cd4 and Il17rb transcripts were correlated with the surface
expression of these molecules (Figures 3A and S5A). Il2rb
(=Cd122) expression was restricted to CD4
2 and CD4
+, IL-
17RB
2 iNKT cell subtypes (Figures 3A and S5A) in correlation
with their surface protein expression (Figure 2C). The expression
levels of TH1-related transcripts, such as Ifng, Tbx21, and Stat4,
were more than 10 times higher in those of CD4
2 and CD4
+ IL-
17RB
2 iNKT cells. Higher levels of TH2-related transcripts, such
as Il4, were detected in CD4
+ IL-17RB
+ iNKT cells, even though
Gata3, a transcription factor essential for TH2 cytokine production,
was expressed at a similar level in all subtypes (Figures 3B and
TH2- and TH17-Cytokine-Producing iNKT Cells
PLoS Biology | www.plosbiology.org 4 February 2012 | Volume 10 | Issue 2 | e1001255Figure 2. Profile of iNKT cells in the thymus of Il17rb
2/2 and Il15
L117P mice. (A, B) FACS profiles of thymus (A) and enriched thymic iNKT cells
(B) in WT, Il17rb
2/2 and Il15
L117P mice on a B6 background. (A) a-GalCer/CD1d dimer
+ iNKT cells were slightly decreased in Il17rb
2/2 mice and
markedly reduced in Il15
L117P mice. (B) There was a loss of the NK1.1
2 population in Il17rb
2/2 thymic iNKT cells, while Il15
L117P thymic iNKT cells
showed impairment of the NK1.1
+ population. (C) IL-17RB and CD122 expression by thymic iNKT cell populations of B6 mice. IL-17RB and CD122
expression in CD4
2 and CD4
+ of CD44
lo NK1.1
2 (Stage 1), CD44
lo NK1.1
+ (Stage 2), and CD44
hi NK1.1
+ (Stage 3) populations were analyzed. IL-17RB
expression was observed in Stages 1/2, while CD122 expression was in the Stage 3 cells. (D, E) Profiles of thymic iNKT cells in B6 and Il15
L117P mice
showing expression of IL-17RB and CD4 (D) and further divided into CD44 and NK1.1 subpopulations (E). The percentage of IL-17RB
+ iNKT cells was
increased due to the loss of expansion of IL17RB
2 iNKT cells in Il15
L117P mice. CD4
2 and CD4
+, IL-17RB
+ iNKT cells were almost all Stage 1 and Stage 2
in both WT B6 and Il15
L117P mice. On the other hand, the majority of CD4
2 and CD4
+, IL-17RB
2 iNKT cells were Stage 3 in both WT B6 and Il15
L117P
mice. Loss of expansion of CD4
2 and CD4
+, IL-17RB
2 iNKT cells was also observed in Il15
L117P mice. (F, G) Percentage (F) and cell number (G) of the
total iNKT cells and the four subtypes (i.e. IL-17RB
+/2 and CD4
+/2) in B6, Il17rb
2/2 and Il15
L117P mice based on their CD44 and NK1.1 expression
patterns. The number of CD4
2 and CD4
+, IL-17RB
2 iNKT cells was significantly decreased especially in Stage 3 in Il15
L117P mice compared to WT B6
mice. By contrast, CD4
2 and CD4
+, IL-17RB
+ iNKT cells in Il15
L117P mice were present in numbers comparable to WT. Results are representative of
TH2- and TH17-Cytokine-Producing iNKT Cells
PLoS Biology | www.plosbiology.org 5 February 2012 | Volume 10 | Issue 2 | e1001255S5B). On the other hand, the expression of TH17-related
transcripts, such as Il17a, Il22, and Rorc, were restricted to the
CD4
2 IL-17RB
+ iNKT cells (Figures 3B and S5B).
We then investigated the gene expression level in cells derived
from Stages 1 and 2 by FT organ culture (Figure 2H and 2I).
Consistent with the findings above, Ifng expression was restricted
to the cells derived from CD4
2 and CD4
+, IL-17RB
2 iNKT
precursors (Figure S6A and S6B). Higher levels of Il4 were
detected in CD4
+ IL-17RB
+ derived cells and restricted expression
of Il17a in cells derived from CD4
2 IL-17RB
+ precursors (Figure
S6A and S6B), supporting each subtype arise from Stage 1 as a
functionally distinct subtype.
Based on these findings, we analyzed potential production of
cytokines from these thymic iNKT cell subtypes. Sorted iNKT cell
subtypes were stimulated with PMA plus ionomycin (Figure S7A).
Similar to the cytokine expression, IFN-c was exclusively produced
by the CD4
2 and CD4
+, IL-17RB
2 subtypes, while IL-10 and IL-
13 were mainly produced by the CD4
+ IL-17RB
+ iNKT cells and
IL-17A was produced predominantly by CD4
2 IL-17RB
+ iNKT
cells. It should be noted that all four subtypes have a potential to
produce IL-4, in correlation with their mRNA expression of Il4
and Gata3 (Figures 3B and S5B).
We then further analyzed cytokine production after a-GalCer
activation. Sorted iNKT cell subtypes were co-cultured with BM-
DCs in the presence of a-GalCer (Figures 3C and S5C). IFN-c was
exclusively produced by the CD4
2 and CD4
+, IL-17RB
2
subtypes, while IL-4, IL-9, IL-10, and IL-13 were mainly
produced by the CD4
+ IL-17RB
+ iNKT cells. Similarly, IL-17A
and IL-22 were produced predominantly by CD4
2 IL-17RB
+
iNKT cells. These cytokine production patterns correlated with
their differential expression of TH1/TH2/TH17-related genes in
the different iNKT subtypes.
We also analyzed the expression profiles of cytokine receptor
genes. Il12rb2 transcript was expressed in CD4
2 and CD4
+, IL-
17RB
2 iNKT cells, and Il23r expression was restricted to CD4
2
IL-17RB
+ iNKT cells (Figures 3D and S5D), suggesting that
CD4
2 and CD4
+, IL-17RB
2 iNKT cells respond to IL-12
through IL-12Rb2/IL-12Rb1, while CD4
2 IL-17RB
+ iNKT cells
respond to IL-23 through IL-23R/IL-12Rb1. In fact, CD4
2 and
CD4
+, IL-17RB
2 iNKT cells produced large amounts of IFN-c
but not TH2 and TH17 cytokines in response to IL-12 (Figures 3E
and S5E), while CD4
2 IL17RB
+ iNKT cells produced large
amounts of TH17 cytokines, IL-17A and IL-22, but not IFN-c and
TH2 cytokines in response to IL-23 (Figures 3F and S5F). IL-25-
mediated activity requires not only IL-17RB but also IL-17RA
expression [26], which is expressed on all iNKT cell subtypes
(Figures 3D and S5D). IL-25 acts on thymic CD4
+ IL-17RB
+
iNKT cells to induce a large amount of TH2 cytokines, along with
moderate amounts of TH17 cytokines (Figures 3G and S5G)
similar to previous observations in the CD4
+ IL-17RB
+ iNKT cell
subtype in the spleen [17]. Interestingly, however, IL-25 does not
stimulate CD4
2 IL-17RB
+ iNKT cells, despite their expression of
IL-17RB (Figures 3G and S5G). We also found that cytokine
production from iNKT cells in these experimental settings was
hardly observed when BM-DCs derived from Cd1d1
2/2 mice
(unpublished data), indicating signals from TCR are also required
for cytokine production from iNKT cells. These results suggest
that three types of iNKT cells, i.e. CD4
2 IL-17RB
+ (iNKT-TH17,
IL-23 reactive), CD4
+ IL-17RB
+ (iNKT-TH2/17, IL-25 reactive),
and CD4
2 and CD4
+, IL-17RB
2 (iNKT-TH1, IL-12 reactive),
exist as distinct subpopulations in the thymus.
The chemokine receptor expression patterns are also distinct
among thymic iNKT cell subtypes. Ccr4 and Ccr7 expression was
restricted to both CD4
2 and CD4
+, IL-17RB
+ iNKT cells, and
Ccr6 expression was only observed on CD4
2 IL-17RB
+ iNKT cells
(Figures 3H and S5H). Cxcr3 expression was several times higher
on IL-17RB
2 iNKT cells than on the other subtypes. Surprisingly,
the expression of Cxcr6, which has been reported to be abundantly
expressed by all iNKT cells [27,28], was also restricted to the IL-
17RB
2 iNKT cells (Figures 3H and S5H). Note that the
expression patterns and levels of all of the genes tested were
almost equivalent between B6 and BALB/c mice, consistent with
our finding that all iNKT subtypes are present in these strains.
Distribution of iNKT Subtypes in the Periphery
Distinct expression of chemokine receptors among thymic
iNKT cell subtypes (Figures 3H and S5H) may reflect the
differential distribution of iNKT cell subtypes in the periphery. We
thus investigated the frequency of total iNKT cells and subtypes in
the spleen, liver, BM, lung, inguinal lymph node (LN), and
mesenteric LN in WT B6, BALB/c, and Il17rb
2/2 mice (Figures 4
and S8). The absolute number and percentage of iNKT cells were
slightly decreased in the spleen, lung, inguinal LN, and mesenteric
LN of Il17rb
2/2 mice, but were unchanged compared to WT mice
in liver and BMs (Figures 4A and S8A). We then gated on a-
GalCer/CD1d dimer
+ TCRb
+ iNKT cells and further analyzed
them for the expression of CD44 and NK1.1 in B6 background
mice (Figure 4B). The percentage of NK1.1
2 subtype cells was
higher in the spleen, lung, inguinal LN, and mesenteric LN, but
lower in the liver and BM, and was decreased in Il17rb
2/2 mice,
suggesting that the majority of iNKT cell subtypes maintain
surface expression of NK1.1
2 after emigration from the thymus
(Figure 2B). Similarly, we examined the expression of CD4 and IL-
17RB on the iNKT subtypes (Figures 4C and S8B). Interestingly,
IL-17RB
+ iNKT cells were abundant in the lung, inguinal LN,
and mesenteric LN, but barely detectable in the liver and BM of
both B6 and BALB/c mice. More than 40% of iNKT cells were
IL-17RB
+ in the lung, inguinal LN, and mesenteric LN, whereas
more than 90% were IL-17RB
2 in the liver and BM (Figures 4C
and S8B). Therefore, the distribution patterns of the iNKT cell
subtypes are distinct in the tissues. In agreement with a previous
study [21], we found that the number of iNKT cells was decreased
in the spleen (,1/3) and liver (,1/30) in Il15
L117P mice (Figure
S9A). Reduction of iNKT cell number was also observed in BM
(,1/8) in these mice (Figure S9A), probably due to the selective
reduction of the IL-17RB
2 subtypes (Figure S9B). We finally
compared iNKT cell subtypes in the thymus and periphery of B6
and BALB/c mice (Figure 4D). The total iNKT cell number was
almost equivalent between these two strains, but BALB/c had ,4
times more CD4
+ IL-17RB
+ subtype cells, but lower (,1/3)
numbers of CD4
2 IL-17RB
2 cells, resulting in a higher number of
CD4
+ IL-17RB
+ cells in the spleen (,5 times), lung (,2 times),
inguinal LN (,1.5 times), mesenteric LN (,4 times), and lower
those from three independent experiments. (H, I) Development of iNKT subtypes in Stages 1 and 2. Stage 1 and 2 cells in the four iNKT subtypes (i.e.
IL-17RB
+/2 and CD4
+/2) from WT B6 mice were sorted and cocultured with dGuo treated 15 dpc FT lobes from Ja18
2/2 mice (1,000 cells/well). 10 d
after culture, cells were recovered and analyzed the surface expression pattern in CD44 versus NK1.1 (H) and CD4 versus IL-17RB (I). IL-17RB
2
precursors gave rise through Stage 2 to Stage 3 cells with IL-17RB
2, while IL-17RB
+ subtypes gave rise to Stage 2 cells with IL-17RB
+. Results are
representative of those from three independent experiments.
doi:10.1371/journal.pbio.1001255.g002
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2 IL-17RB
2 cells, especially in liver (,1/6) and
BM (,2/5) of BALB/c mice (Figure 4D).
To confirm the distribution profiles of each subtype in the
periphery, we performed intracellular cytokine staining after PMA
plus ionomycin stimulation (Figure S7B) and quantitative real-time
PCR analysis (Figure S10A–D) on these iNKT cells that were
tested in the thymic iNKT cell subtypes (Figures 3A, 3B, 3D, 3H,
S7A). The gene expression profiles and potential cytokine
production in the iNKT cell subtypes were almost equivalent
among those in the different peripheral tissues, but higher than
those in the thymus, strongly suggesting that each iNKT subtype
in the periphery is derived from the same iNKT subtypes in the
thymus.
IL-17RB
+ iNKT Cells as TH2/TH17-Producing iNKT Subtypes
We next compared global gene expression profiles of CD4
2 or
CD4
+, IL-17RB
+ or IL-17RB
2 iNKT subtypes in the thymus and
spleen in order to test whether each subtype is functionally and
phenotypically stable or plastic. Each of the four subtypes in spleen
was highly correlated with the corresponding subtype in the
thymus (Figure 5A), suggesting that iNKT subtypes can be divided
by CD4 and IL-17RB expression both in the thymus and the
Figure 3. Differential gene expression and cytokine production among thymic iNKT cell subtypes from B6 mice. (A, B, D, H)
Quantitative PCR analysis of thymic iNKT subtypes. Thymic iNKT cells further divided into four subtypes based on the expression of CD4 and IL-17RB
(red, CD4
2 IL-17RB
+; orange, CD4
+ IL-17RB
+; blue, CD4
2 IL-17RB
2; green, CD4
+ IL-17RB
2). One representative out of three experiments is shown
(mean 6 SEM). (A) The purity of the sorted cells was confirmed by the relative Il17rb and Cd4 mRNA expression levels in the respective subtypes. Il2rb
(=Cd122) expression was restricted to CD4
2 and CD4
+, IL-17RB
2 iNKT cells. (B) Expression of TH1/TH2/TH17 related genes. TH1 related: Ifng, Tbx21 and
Stat4,T H2 related; Il4 and Gata3, and TH17 related: Il17a, Il22 and Rorc transcripts were analyzed. (D) Expression of cytokine receptor genes. Receptor
for IL-12, IL-23, and IL-25 were analyzed. The component chains of the various receptors are IL-12 receptor: IL-12Rb2/IL-12Rb1; IL-23 receptor: IL-23R/
IL-12Rb1; IL-25 receptor: IL-17RB/IL-17RA. (H) Expression of chemokine receptor genes. Ccr4, Ccr6, Ccr7, Cxcr3, and Cxcr6. (C, E, F, G) In vitro cytokine
production by thymic iNKT cell subtypes (red, CD4
2 IL-17RB
+; orange, CD4
+ IL-17RB
+; blue, CD4
2 IL-17RB
2; green, CD4
+ IL-17RB
2). Sorted thymic
iNKT subtypes (5610
4 cells/100 mL) were co-cultured with BM-DCs (5610
3/100 mL) for 48 h in the presence of a-GalCer (100 ng/mL) (C), IL-12 (10 ng/
mL) (E), IL-23 (10 ng/mL) (F), or IL-25 (10 ng/mL) (G). Levels of IFN-c, IL-4, IL-9, IL-10, IL-13, IL-17A, and IL-22 were analyzed. The data are representative
of three independent experiments (mean 6 SEM).
doi:10.1371/journal.pbio.1001255.g003
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(Figure S10) showed similar quantitative gene expression profiles
as in the thymus (Figure 3).
In order to confirm the stability and plasticity of iNKT cell
subtypes, we sorted thymic iNKT cell subtypes based on the
expression of CD4 and IL-17RB from WT B6 and transferred
them into iNKT cell-deficient Ja18
2/2 mice. Ten days after
transfer, we analyzed the IL-17RB expression by iNKT cell
subtypes in the spleen. The results clearly showed that the majority
of transferred cells maintained their surface IL-17RB expression
Figure 4. iNKT cell subtypes in the periphery. (A–C) FACS profile of peripheral iNKT cells in B6 mice. a-GalCer/CD1d dimer
+ TCRb
+ iNKT cells (A)
and iNKT subtypes based on the expression of CD44 and NK1.1 (B) or CD4 and IL-17RB (C) in spleen, liver, BM, lung, inguinal LN, and mesenteric LN
from B6 or Il17rb
2/2 mice. Numbers indicate percentage of total mononuclear cells (A) and iNKT cells (B, C). (D) Number of cells of each iNKT subtype
based on the expression of IL-17RB and CD4 in thymus and periphery of B6 and BALB/c mice. Cell numbers were calculated based on the results from
Figures 4A, 4C, S8A, and S8B. IL-17RB
+ iNKT cells were mainly localized in spleen, lung, inguinal LN, and mesenteric LN, whereas hardly any were
observed in liver and BM. One representative experiment of three is shown.
doi:10.1371/journal.pbio.1001255.g004
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cells migrate from the thymus to the periphery.
We further analyzed in cytokine production of splenic iNKT
cell subtypes from B6 and BALB/c mice. The cytokine production
profiles of splenic iNKT cell subtypes in response to a-GalCer
(Figures 5C and S11A), IL-12 (Figures 5D and S11B), IL-23
(Figures 5E and S11C), and IL-25 (Figures 5F and S11D) were
quite similar to those of the thymic iNKT cell subtypes (Figures 3C,
3E, 3F, 3G, S5C, S5E, S5F, S5G). Taken together, all of the
iNKT subtypes detected in the thymus also exist as phenotypically
and functionally distinct subtypes in the peripheral tissues.
E4BP4 Is Required for the Production of IL-9, IL-10, IL-13,
IL-17A, and IL-22 Cytokines by CD4
+ IL-17RB
+ iNKT Cells
in Response to IL-25
Both thymic and peripheral iNKT cells in the steady state
contain Ifng mRNA in the CD4
2 and CD4
+, IL-17RB
2 cells
(Tbx21 expressed, iNKT-TH1, IL-12 reactive), and Il17a and Il22
mRNA in the CD4
2 IL-17RB
+ cells (Rorc expressed, iNKT-TH17,
IL-23 reactive). The expression of these cytokine transcripts is
thought to result from the fact that peripheral iNKT cells are not
truly quiescent, but instead appear to be continuously activated at
a low level due to their recognition of endogenous self-glycolipid
ligand(s) in vivo. However, the CD4
+ IL-17RB
+ iNKT cells do not
contain Il9, Il10, Il13 (unpublished data), Il17a,o rIl22 mRNA
(Figures 3B, S5B, S10B) in the steady state, even though these
cytokines are immediately produced after activation by a-GalCer,
similar to cases of IFN-c from IL-17RB
2 iNKT cells. These results
suggest differences in the transcriptional regulation of cytokine
genes in the different iNKT cell subtypes.
One of the candidate genes is E4BP4, a mammalian basic
leucine zipper transcription factor that regulates IL-10 and IL-13
production not only by CD4
+ T cells and regulatory T cells but
also by iNKT cells [29]. E4BP4 expression was markedly induced
in IL-25-treated iNKT cells, and its expression level correlated
with Il10 and Il13 expression [29]. Furthermore, iNKT cells
lacking E4bp4 had reduced expression of IL-10 and IL-13 in
response to either IL-25 or a-GalCer stimulation, but the IFN-c
and IL-4 production were unaffected [29], indicating that E4bp4
controls the TH2 cytokine production in a particular iNKT cell
subtype.
Therefore, we analyzed the role of E4bp4 in iNKT cell subtypes.
The expression of E4bp4 was selectively and strongly induced by
IL-25 treatment in CD4
+ IL-17RB
+ iNKT cells both from thymus
Figure 5. Function of iNKT cell subtypes in the spleen. (A) Global gene expression profiles in iNKT subtypes in the thymus and spleen. Tree
view representation of clustering analysis among the four iNKT subtypes in thymus and spleen from B6 and BALB/c. The values represent coefficients
between the indicated panels. r
2.0.95 in red, 0.85,r
2,0.95 in orange, and r
2,0.85 in blue. One representative experiment of three is shown. (B)
Plasticity and stability of iNKT subtypes. The four iNKT cell subtypes in the thymus were sorted and each subtype (5610
5) was i.v. transferred into
independent Ja18
2/2 mice (n=3). 10 d after transfer, a-GalCer/CD1d dimer
+ TCRb
+ cells in spleen were analyzed by FACS for the expression of IL-
17RB and CD4. Representative data from three experiments are shown. (C–F) In vitro cytokine production by splenic iNKT cell subtypes (red, CD4
2 IL-
17RB
+; orange, CD4
+ IL-17RB
+; blue, CD4
2 IL-17RB
2; green, CD4
+ IL-17RB
2). Sorted splenic iNKT subtypes (5610
4 cells/100 mL) were co-cultured with
BM-DCs (5610
3/100 mL) for 48 h in the presence of a-GalCer (100 ng/mL) (C), IL-12 (10 ng/mL) (D), IL-23 (10 ng/mL) (E), and IL-25 (10 ng/mL) (F). Levels
of IFN-c, IL-4, IL-9, IL-10, IL-13, IL-17A, and IL-22 in the supernatants were analyzed by ELISA or CBA. Data are mean 6 SD of triplicate wells. One
representative experiment of three is shown.
doi:10.1371/journal.pbio.1001255.g005
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2 IL-17RB
+ iNKT cells
failed to induce E4bp4 expression even after treatment with IL-23
(Figure 6B), suggesting the cell type-specific function of E4bp4 and
its possible role not only in Il10 and Il13 expression but also in Il9,
Il17a, and Il22 expression by IL-25-treated CD4
+ IL-17RB
+
iNKT cells. To test this hypothesis, we analyzed cytokine
production by CD4
+ IL-17RB
+ iNKT cells lacking E4bp4 after
treatment with IL-25 in the presence of BM-DCs (Figure 6C). The
production of IL-9, IL-10, IL-13, IL-17A, and IL-22 cytokines by
both thymic or splenic CD4
+ IL-17RB
+ iNKT cells in response to
IL-25 was completely abrogated, indicating E4BP4 turned out to
be an intrinsic regulator of IL-25-mediated production, not only of
IL-10 and IL-13 but also of IL-9, IL-17A, and IL-22.
Involvement of IL-17RB
+ iNKT Cells in the Pathogenesis of
Virus-Induced AHR
We then investigated the role of IL-17RB
+ iNKT cells in the
pathogenesis of virus-induced AHR, which is known to be
different from allergen-induced AHR [30]. Certain viruses, such
as respiratory syncytial virus (RSV), Sendai virus, metapneumo-
virus, and parainfluenza virus, cause childhood asthma and
COPD-like symptoms, which include AHR, airway inflammation,
and mucus hypersecretion [31–33]. However, it has been very
difficult to understand how such symptoms develop, even long
after the apparent clearance of viruses. It has been reported that,
in mouse models of infection with parainfluenza virus or Sendai
virus, virus-induced chronic inflammation leads to asthma that
resembles human asthma and COPD [34]. The chronic
pulmonary symptoms evolved independently of CD4
+ T cells
but required CD4
2 iNKT cells and did not occur in Cd1d
2/2 and
Ja18
2/2 mice [34].
Therefore, we attempted to determine whether or not the
CD4
2 IL-17RB
+ iNKT cells are responsible for chronic
inflammatory lung disease induced by RSV infection. We used
the secreted form of recombinant G protein of RSV (rec Gs)
(Figure S12) as an immunogen because priming with a
recombinant vaccinia virus (rVV) expressing rec Gs induced a
more TH2-biased response and enhanced pulmonary eosinophil
and macrophage infiltration following RSV challenge than did
priming with rVV expressing either wild-type G or membrane
anchored G (Gm) proteins [35,36]. Mice were inoculated i.n. with
RSV (10
6 pfu/100 ml) or PBS as a control four times at 10-d
intervals and were intraperitoneally (i.p.) immunized with rec Gs/
alum (50 mg/2 mg) 4 d after the first RSV infection. Three days
after the last RSV administration, mice were exposed i.n. to 50 mg
rec Gs and then, 24 h later, measured for AHR (Figure 7A). In this
experimental setting, RSV/rec Gs-induced AHR was observed in
WT BALB/c but not in Ja18
2/2 or Il17rb
2/2 mice, which had a
similar response level as PBS/rec Gs-induced WT controls,
indicating that IL-17RB
+ iNKT cells contribute to the develop-
ment of RSV plus viral antigen-induced AHR (Figure 7B). Airway
macrophage and lymphocyte numbers, which were relatively
higher than eosinophils and neutrophils, were recruited into the
bronchoalveolar lavage (BAL) fluid of RSV/rec Gs-induced WT
mice but not the other mice (Figure 7C). These results suggest that
IL-17RB
+ iNKT cells are required for the development of RSV-
induced AHR. Low level of cytokines (IL-4, IL-9, IL-10, IL-13, IL-
17A, and IL-22) in the BAL fluid was detected in this experiment
(Figure 7D). The production of IL-13 and IL-22, which plays a
crucial role in the activation of macrophages and neutrophils,
respectively, was detected higher in RSV/rec Gs-induced WT
mice. Hematoxylin and eosin (H&E) staining of the lung tissue
revealed that a large number of inflammatory mononuclear cells
had infiltrated into the peribronchiolar region, a response that was
higher in RSV/rec Gs-induced WT mice compared to RSV/rec
Gs-induced Ja18
2/2 or Il17rb
2/2, mice (Figure 7E, upper panel).
By periodic acid-Schiff (PAS) staining, mucus-producing cells were
abundant only in RSV/rec Gs-induced BALB/c mice but not in
Ja18
2/2 or Il17rb
2/2 mice (Figure 7E, lower panel). To confirm
the findings that IL-17RB
+ iNKT cells are essential for the
development of RSV/rec Gs-induced AHR, we transferred
enriched splenic IL-17RB
+ iNKT cells into Ja18
2/2 mice and
tested their ability to develop AHR (Figure 7F). The cell transfer of
IL-17RB
+ iNKT cells, but not IL-17RB
2 iNKT cells nor PBS
alone, restored AHR induced by RSV plus rec Gs, dependent of
cell number transferred, demonstrating the important contribution
of IL-17RB
+ iNKT cells in the pathogenesis of development in
virus plus viral antigen-induced AHR.
Discussion
In the present study, we identified IL-17RB
2 and IL-17RB
+
subtypes of iNKT cells both in the thymus and the periphery. The
IL-17RB
2 iNKT cells express CD122 (IL-15Rb chain), expand in
an IL-15-dependent manner, and produce IFN-c in response to
IL-12. On the other hand, the IL-17RB
+ iNKT cells do not
express CD122 or respond to IL-15. The IL-17RB
+ iNKT cells
can be further divided into at least two subtypes: (1) CD4
+ IL-
17RB
+ iNKT cells produce TH2, TH9, and TH17 cytokines in an
E4BP4-dependent fashion in response to IL-25, and (2) CD4
2 IL-
17RB
+ iNKT cells are RORct
+ and produce TH17 cytokines in
response to IL-23, but independently of E4BP4. In the thymus, the
IL-17RB
+ iNKT cells have a developmental pathway distinct from
the IL-17RB
2 iNKT cells.
It has been proposed that iNKT cell differentiation stages can
be categorized based on the expression patterns of CD44 and
NK1.1, for example CD44
lo NK1.1
2 for Stage 1, CD44
hi NK1.1
2
for Stage 2, and CD44
hi NK1.1
+ for Stage 3 [14,25]. However, the
majority (.80%) of IL-17RB
+ iNKT cells was present in both the
Stage 1 and Stage 2 subsets, while IL-17RB
2 iNKT cells were
enriched in Il17rb
2/2 mice and were mainly detected in Stage 3,
suggesting that a certain but not all of the Stage 1 and Stage 2 IL-
17RB
+ iNKT cells are not precursors for the Stage 3 cells. It is
believed that iNKT cells acquire their ability to produce IL-4 and
IL-10, but make little IFN-c in Stages 1/2 populations, whereas
iNKT cells in Stage 3 produce abundant IFN-c but less if any IL-
10 [14,15,25,37]. These finding are in agreement with the present
results that the Stage 1/2 populations mainly contain IL-17RB
+
iNKT cells that can produce IL-4 and IL-10, but not IFN-c,
whereas the majority of the Stage 3 iNKT cells are IL-17RB
2
iNKT cells producing IFN-c but not TH2 cytokines. The results
shown here also indicated that all of the four iNKT subtypes
already existed in Stage 1 and developed into phenotypically and
functionally distinct iNKT cells as CD4
2 or CD4
+, IL-17RB
+ in
Stage 2 and CD4
2 or CD4
+, IL-17RB
2 through Stage 2 to Stage
3.
It has reported that IL-15 plays an important role in the
expansion of iNKT cells [21]. Our present data showed that IL-15
requires only for the expansion of IL-17RB
2 iNKT cell subtypes
but not for IL-17RB
+ iNKT cells, even though it has still been
unclear that the cytokine(s) are required for the development and
expansion of IL-17RB
+ subtypes. In fact, IL-17RB
2 iNKT cell
subtypes were greatly reduced in number among iNKT cell
subtypes but already had an ability to produce IFN-c in Il15
L117P
mice, resulting in the reduced IFN-c production after iNKT cell
activation due to the reduced number of these subtypes.
In the previous reports, the IL-17A-producing subtypes were
proposed to be contained within the CD44
hi NK1.1
2 CD4
2
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+ subpopulation [8,19]. In the present studies, we found
that the CD4
2 IL-17RB
+ iNKT cell subtype is CD44
hi NK1.1
2
CD4
2 (about 50%–70% of the cells are IL-17RB
+) and has a
restricted expression of Il17a, Rorc, Ccr6, and Il23r genes, for a
phenotype similar to the previously reported CD44
+ NK1.1
2
CD4
2 RORct
+ population that produces IL-17A [19,38]. These
results indicate that IL-17RB (and CD4
2) is a reliable and specific
phenotypic marker for RORct
+ IL-17A-producing iNKT cells in
the thymus.
In the periphery, the tissue distribution of the iNKT cell
subtypes seems to largely depend on the expression of chemokine
receptors: CCR6
+ CCR4
+ CCR7
+ expression by CD4
2 IL-17RB
+
iNKT cells, CCR4
+ CCR7
+ expression by CD4
+ IL-17RB
+ iNKT
cells, and CXCR3
+ CXCR6
+ by CD4
2 and CD4
+, IL-17RB
2
iNKT cells. Indeed, the number of liver iNKT cells, the majority
of which are the CD4
2 and CD4
+, IL-17RB
2 iNKT cells
identified here, depends on the chemokine receptor CXCR6,
whereas iNKT cells in other tissues are less dependent as reported
[27,28]. In Ccr4
2/2 mice, the lung has fewer iNKT cells and a
corresponding reduction in iNKT cell-mediated AHR [39],
implicating the reduction of pulmonary localization of IL-17RB
+
iNKT cells.
IL-17A-producing iNKT cells have been described in other
studies in the thymus, liver, spleen, lung, LNs, and skin
[8,19,20,38,40]. In these studies, it was suggested that all
NK1.1
2 iNKT cells have the potential to secrete IL-17A.
However, in the present study, we show heterogeneity among
NK1.1
2 iNKT cells. Accordingly, CD4
2 but not CD4
+, IL-
17RB
+ iNKT cells correspond to the IL-17A-producing iNKT
cells previously reported, as does the exclusive expression of Ccr6
along with Itgae (=Cd103) and Il1r1 (=Cd121a) in CD4
2 IL-
17RB
+ iNKT cells (unpublished data) [40].
CD4
+ IL-17RB
+ iNKT cells produce not only the previously
described IL-13 and IL-4 [17,18] but also IL-9 and IL-10 along
with IL-17A and IL-22 in response to IL-25 in an E4BP4-
dependent fashion. Even though it is still unclear whether IL-25-
reactive CD4
+ IL-17RB
+ iNKT cells can be further divided into
differentially functional subsets (i.e. iNKT-TH2, iNKT-TH9,
iNKT-TH17), it is noteworthy that a recently described subset of
differentiated T cells [41], termed TH9, which can be induced by
IL-4 plus TGF-b, produces IL-9 and IL-10 in response to IL-25.
This IL-9 production is IL-4 independent, highlighting the role of
IL-25 in the regulation of both TH2 and TH9 cells [42]. We
demonstrated here that IL-25 induces not only IL-13 and IL-4 but
also IL-9 and IL-10 from CD4
+ IL-17RB
+ iNKT cells, which can
thus be characterized as iNKT-TH2 and iNKT-TH9 cells.
Concerning the cytokine production by CD4
+ IL-17RB
+ iNKT
cells in response to IL-25, not only IL-10 and IL-13 but also IL-9,
Figure 6. Involvement of E4bp4 in cytokine production by CD4
+ IL-17RB
+ iNKT cells in response to IL-25. (A, B) Quantitative analysis of
Rorc (A) and E4bp4 (B) in iNKT cell subtypes after cytokine treatment. Sorted iNKT cell subtypes (5610
4/100 mL) from thymus (left) or spleen (right)
were co-cultured with BM-DCs (5610
3/100 mL) in the presence or absence of IL-23 (10 ng/ml) or IL-25 (10 ng/ml) for 24 h. The iNKT cell subtypes
were then sorted again and analyzed for expression of the indicated genes by quantitative real-time PCR. The data are representative of three
independent experiments (mean 6 SEM). (C, D) Cytokine production by CD4
+ IL-17RB
+ iNKT cells in response to IL-25. Sorted CD4
+ IL-17RB
+ iNKT cells
(5610
4/100 mL) from thymus (C) or spleen (D) of B6 or E4bp4
2/2 mice were co-cultured with BM-DCs (5610
3/100 mL) in the presence of IL-25 (10 ng/
ml) for 48 h and then the levels of the indicated cytokines in the tissue culture media were analyzed. iNKT cells from B6 were compared to those from
E4bp4
2/2 mice. ** p,0.01 calculated by t test. The data are representative of three independent experiments (mean 6 SD).
doi:10.1371/journal.pbio.1001255.g006
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recently defined as a transcription factor that regulates IL-10 and
IL-13 production by CD4
+ T cells and iNKT cells [29], suggesting
that E4BP4 also controls IL-25-mediated production of IL-9, IL-
17A, and IL-22. Although the precise mechanisms by which IL-25
mediates cytokine expression still remains unclear, E4BP4 itself
directly or indirectly controls IL-9, IL-10, IL-13, IL-17A, and IL-
22 expression by genetic/epigenetic regulation in CD4
+ IL-17RB
+
iNKT subtypes. It will be of interest to determine if E4BP4
regulates IL-9, IL-17A, and IL-22 production by CD4
+ TH cells.
Taken collectively, our studies indicate that CD4
2 or CD4
+, IL-
17RB
+ iNKT cells become functionally stable iNKT-TH17 or
iNKT-TH2/9/17, respectively, during their development.
The study described here indicates that iNKT cell-mediated
AHR was not induced by viral infections in Ja18
2/2 or Il17rb
2/2
mice, suggesting that IL-17RB
+ iNKT cells are responsible for the
pathogenesis of many different forms of airway inflammation.
Although distinct subsets of iNKT cells have been reported to be
involved in different forms of asthma [17,18,34,43], they are now
consolidated into CD4
2 and/or CD4
+ IL-17RB
+ iNKT cell
subsets.
iNKT cells are also known to mediate regulatory functions
controlling various pathological conditions, such as infectious
diseases caused by microbes [44], autoimmune diseases (colitis,
lupus, diabetes) [45,46], atherosclerosis [47], and malignancy [48].
It will be interesting to elucidate whether subsets of iNKT cells
Figure 7. Involvement of IL-17RB
+ iNKT cells in the development of RSV-induced AHR. (A) Schematic showing the protocol for RSV-
induced AHR. Mice were i.n. administered with RSV (10
6 pfu) or PBS alone as a control 4 times at 10-day intervals. Mice were i.p. immunized with rec
Gs/alum (50 mg/2 mg) 4 d after first RSV infections. Three days after the last RSV administration, mice were exposed i.n. to rec Gs and were measured
1 d later. (B) Development of RSV-induced AHR in BALB/c, but not in Ja18
2/2 or Il17rb
2/2 mice. Changes in RL are depicted. The RSV-infected, rec Gs
immunized, BALB/c mice had a greatly increased AHR compared to the other three groups. Results are expressed as the mean 6 SEM. * p,0.05 and
** p,0.01. (C, D) Total and differential cell counts (C) and cytokines (D) in BAL fluid. BAL fluid was collected 24 h after challenge of the mice depicted
in (B) with intranasal rec Gs. Results are expressed as the mean 6 SEM. * p,0.05 and ** p,0.01. (E) Histological examination of lung tissues by H&E
and PAS staining. RSV infected, rec Gs immunized, BALB/c, Ja18
2/2 or IL17rb
2/2, mice were compared with control BALB/c mice (rec Gs alone). Bars
indicate 100 mm. (F) AHR development after cell transfer of spleen IL-17RB
+ iNKT cells into Ja18
2/2 mice. Indicated cell numbers of sorted IL-17RB
+, IL-
17RB
2 iNKT cells or total iNKT cells from spleen, or PBS control, were i.v. transferred into rec-Gs/alum-sensitized Ja18
2/2 mice 24 h before RSV
treatment (on the day 9, 19, and 29), and then challenged with rec Gs (24 h) and measurement of lung resistance (48 h). Each group of IL-17RB
+ iNKT
cell-transferred mice was compared to other three groups. * p,0.05, ** p,0.01 calculated by Kruskal Wallis test. The results represent one out of four
experiments with five mice in each group.
doi:10.1371/journal.pbio.1001255.g007
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pathological conditions.
Materials and Methods
Mice
B6 and BALB/c mice were purchased from Charles River
Laboratories or Clea Japan, Inc. Il17rb-deficient mice were
generated as shown in Figure S1 and were backcrossed .8 times
to B6 or BALB/c mice. Il15
L117P mutant mice were produced by
N-Ethyl-N-nitrosourea (ENU) mutagenesis by ENU administration
to male C57BL/6J mice, and their sperm was mated to wild-type
eggs and preserved as founder embryos [49,50]. Ja18-deficient
mice were generated as previously described [51] and were
backcrossed .10 times to B6 or BALB/c mice. Cd1d1-deficient
mice [52] were provided by Dr. Luc van Kaer (Nashville, TN).
E4bp4-deficient mice were generated as previously described and
were backcrossed 8 times to B6 mice [29]. All mice were kept
under specific pathogen-free conditions and were used at 8–16 wk
of age. All experiments were in accordance with protocols
approved by the RIKEN Animal Care and Use Committee.
Cytokine Measurement
Cytokines except IL-22 in culture supernatants and BAL fluids
were analyzed by cytometric bead array (BD Biosciences)
according to the manufacturer’s protocol. IL-22 was quantified
by an ELISA reagent set (eBioscience) according to the
manufacturer’s protocol.
Flow Cytometry and Cell Sorting
Cells were analyzed by FACS Calibur (BD Biosciences) or
FACS Canto II (BD Biosciences) and sorted by FACS Aria (BD
Biosciences). Antibodies (BD Biosciences or eBioscience) used for
staining mouse cells were as follows: FITC or APC-Cy7 anti-
TCRb (H57-597), Pacific blue anti-CD4 (RM4-5), FITC anti-
CD44 (IM7), PE-Cy7 anti-NK1.1 (PK136), PE anti-CD122 (TM-
b1), FITC anti-CD8a (53-6.7), PerCP-Cy5.5 anti-CD25 (PC61),
PE anti-IFN-c (XMG1.2), PE anti-IL-4 (11B11), PE anti-IL-10
(JES5-16E3), PE anti-IL-13 (eBio13A), PE anti-IL-17A (TC11-
18H10), and PE rat IgG1 (A110-1). Biotinylated anti-mouse IL-
17RB (B5F6) was generated previously [17] and detected by
staining with PE or PE-Cy7 Avidin (BD Biosciences). APC a-
GalCer loaded CD1d dimer (BD Biosciences) for iNKT cell
enrichment and detection was prepared as previously described
[53].
Coculture with a FT lobe
The procedures for the coculture with a deoxyguanosine
(dGuo)-treated FT lobe under high oxygen submersion conditions
have been described in detail previously [54,55]. Basically, single
dGuo-treated FT lobes from Ja18
2/2 of B6 background were
placed into wells of a 96-well V-bottom plate, to which cells from
B6 mice to be examined were added. Culture medium was
supplemented with IL-7 (1 ng/ml), IL-15 (10 ng/ml), and soluble
IL-15Ra (10 ng/ml). The plates were centrifuged at 1506 g for
5 min at room temperature, placed into a plastic bag (Ohmi Odor
Air Service), the air inside was replaced by a gas mixture (70% O2,
25% N2, and 5% CO2), and incubated at 37uC. After 10 d of
culture, cells were harvested from each well and analyzed by
FACS and quantitative real-time PCR.
Intracellular Cytokine Staining
Intracellular cytokine staining was performed as described
previously [53]. For cytokine production from sorted iNKT cell
subtypes, Brefeldin A (Sigma-Aldrich) was added for the last 4 to
5 h of culture to accumulate intracellular cytokines after PMA
(25 ng/ml, Sigma) with ionomycin (1 mg/ml, Sigma) treatment.
Following fixation with Cytofix/Cytoperm plus (BD Biosciences),
cells were stained for indicated intracellular cytokines for 15 min
at room temperature.
Quantitative Real-Time PCR
PCR primers and probes were designed with Universal
ProbeLibrary Assay (Roche) or with TaqMan Gene Expression
Assays (Applied Biosystems). Sequence of primers and probes in
the latter case are shown in Table S1. PCR was performed with
the TaqMan universal master mix with ROX (Applied Biosystems)
according to the protocol provided. ABI PRISM7900HT Fast
system (Applied Biosystems) or Biomark system (Fludigm) was used
for quantitative real-time PCR according to the manufacturer’s
instructions. To ensure the specificity of the amplification
products, a melting curve analysis was performed. Results were
normalized and analyzed by DCt or DDCt methods using the
internal control gene Hprt1.
Correlation Analysis of Microarrays
Gene expression detected using microarrays was normalized by
the quantile normalization method [56]. Pearson’s correlation
values of logarithms of all signal intensities from 45,101 probes
were calculated, and we performed hierarchal clustering of
correlation matrices to indicate the degree of similarity between
cell types. Scatter diagrams were drawn to display how similarly or
differently genes were expressed in two samples. These diagrams
contain only probes whose signals were present and coefficient
values were shown in the figures.
RSV-Induced AHR
Strain A2 of human RSV was used in this study. The general
protocol for analyzing airway remodeling during RSV infection
in mice is as follows: AHR was induced by sensitizing and
challenging with OVA/alum (3–4 times) and/or infection with
RSV (3–4 times), and then challenging with OVA, resulting in
the examination of various pathological endpoints as previously
described [57–59]. In the present study, we modified these
protocols in order to analyze the physiological role of iNKT cells
in the development of AHR mediated by RSV. In brief, mice
were i.n. administered with RSV (10
6 pfu) or PBS as a control 4
times at 10-d intervals. Mice were i.p. immunized with rec Gs/
alum (50 mg/2 mg) 4 d after first RSV infections. Three days
after the last RSV administration, mice were exposed i.n. to rec
Gs recombinant protein and AHR responses were measured 1 d
later.
Measurement of Airway Responsiveness
Airway function was measured for changes in lung resistance
(RL) and dynamic compliance in response to increasing doses of
inhaled methacholine (1.25, 2.5, 5, 10, and 20 mg/ml) by using an
invasive FlexiVent (SCIREQ Scientific Respiratory Equipment
Inc.).
Lymphocyte Isolation and Analysis of BAL Fluid
After measurement of AHR and sacrifice, the mouse trachea
was cannulated, the lungs were lavaged twice with 1 ml PBS (10-
fold PBS dilution), and the BAL fluid was pooled as previously
described [30]. Lymphocytes from thymus, spleen, liver, lung, BM,
inguinal LN, and mesenteric LN were isolated as described
previously [53].
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The statistical significance of differences was determined by t
test, analysis of variance (ANOVA), or the Kruskal-Wallis test.
The values were expressed as means 6 SEM from independent
experiments. Any differences with a p value of ,0.05 were
considered significant (* p,0.05; ** p,0.01).
Supporting Information
Figure S1 Generation of Il17rb
2/2 mice. (A) Targeting strategy
to disrupt the il17rb gene. Exons 1 and 2 were substituted with a
neomycin resistance gene. Neo, neomycin; TK, thymidine kinase.
(B) Genomic PCR analysis of offspring from the heterozygote
intercrosses. Genomic DNA was extracted from mouse tails,
amplified with primers indicated in (A). Genomic PCR results gave
a single 500 bp band for wild-type (+/+), a 300 bp band for
homozygous (2/2) and both bands for heterozygous mice (+/2).
(TIF)
Figure S2 Global gene expression profile in thymic iNKT
subtypes. (A, B) Tree view representation of clustering analysis
among the four iNKT subtypes in thymus from WT B6 (A) and
between CD4
2 or CD4
+ IL-17RB
+ cells from WT B6 or Il15
L117P
mice (B). The values represent coefficients between the indicated
panels. r
2.0.9 in red and r
2,0.9 in orange.
(TIF)
Figure S3 In vitro cytokine production by thymic iNKT cells
from Il17rb
2/2 and Il15
L117P mice. Sorted iNKT cells (5610
4/
100 mL) from thymus of WT B6, Il17rb
2/2, and Il15
L117P mice
were co-cultured with BM-DCs (5610
3/100 mL) for 48 h in the
presence of indicated doses of a-GalCer. IFN-c levels from
Il17rb
2/2 iNKT cells were comparable to controls, whereas TH2
and TH17 cytokine levels were severely impaired. By contrast,
IFN-c from Il15
L117P iNKT cells was markedly reduced, whereas
TH2 and TH17 cytokine levels remained constant, which is the
same outcome as in iNKT cells from spleen as shown in Figure 1.
(TIF)
Figure S4 Thymic iNKT cell subtypes in BALB/c mice. (A)
FACS profile of MACS enriched a-GalCer/CD1d dimer
+ TCRb
+
cells from B6 (upper) or BALB/c (lower) mice were further
analyzed for the expression of the indicated markers. (B, C) Tree
view representation of clustering analysis among the four thymic
iNKT cell subtypes in BALB/c mice (B) and in comparison with
thymic iNKT cell subtypes in B6 mice (C). The values represent
coefficients between indicated panels. r
2.0.9 in red and 0.9,r
2 in
orange.
(TIF)
Figure S5 Differential gene expression and cytokine production
among thymic iNKT cell subtypes from BALB/c mice. (A, B, D,
H) Quantitative RT-PCR analysis of thymic iNKT subtypes.
Thymic iNKT cells were further divided into four subtypes based
on the expression of IL-17RB and CD4. The results are shown as
DCt. One representative out of three experiments is shown (mean
6 SEM). (A) Purity of sorted cells was high based on the levels of
Il17rb and Cd4 mRNA expression. Il2rb (=Cd122) expression was
restricted to IL-17RB
2 iNKT cells. (B) Expression of TH1/TH2/
TH17 related genes. TH1: Ifng, Tbx21 and Stat4,T H2:Il4 and
Gata3, and TH17: Il17a, Il22 and Rorc. (D) Expression of cytokine
receptor genes. Receptor for IL-12, IL-23, and IL-25 were
analyzed. IL-12 receptor consists of IL-12Rb2/IL-12Rb1; IL-23
receptor: IL-23R/IL-12Rb1; IL-25 receptor: IL-17RB/IL-17RA.
(H) Expression of chemokine receptor genes. Ccr4, Ccr6, Ccr7,
Cxcr3, and Cxcr6 were analyzed. (C, E, F, G) Cytokine production
by thymic iNKT cell subtypes in vitro. Sorted thymic iNKT
subtypes (5610
4 cells/100 mL) were co-cultured with BM-DCs
(5610
3/100 mL) for 48 h in the presence of a-GalCer (100 ng/mL)
(C), IL-12 (10 ng/mL) (E), IL-23 (10 ng/mL) (F), or IL-25 (10 ng/
mL) (G). Levels of IFN-c, IL-4, IL-9, IL-10, IL-13, IL-17A, and IL-
22 were analyzed. The data are representative of three
independent experiments (mean 6 SEM).
(TIF)
Figure S6 Cytokine gene expression in iNKT cells after being
co-cultured with FT lobes. (A, B) Quantitative RT-PCR analysis of
thymic iNKT precursors developed from Stage 1 (A) and Stage 2
(B) precursors. Cells shown in Figure 2H and 2I were sorted and
analyzed the expression of indicated genes. The results are shown
as DCt. One representative out of three experiments is shown
(mean 6 SEM).
(TIF)
Figure S7 Potential of cytokine production from iNKT cell
subtypes. (A, B) The four iNKT subtypes (i.e. IL-17RB
+/2 and
CD4
+/2) from thymus (A) and spleen (B) were sorted and treated
with PMA and ionomycin. Indicated cytokines produced from
each subtype were analyzed by intracellular cytokine staining.
IFN-c were highly produced from IL-17RB
2 cells, while IL-10,
IL-13 were from CD4
+ IL-17RB
+ subtypes, and IL-17A was from
CD4
2 IL-17RB
+. All four subtypes had a potential to produce IL-
4. The data are representative of three independent experiments.
(TIF)
Figure S8 Peripheral iNKT cell subtypes in BALB/c mice. (A,
B) FACS profiles of peripheral iNKT cells in BALB/c mice. a-
GalCer/CD1d dimer
+ TCRb
+ iNKT cells (A), and iNKT
subtypes based on the expression of IL-17RB and CD4 (B) in
spleen, liver, bone marrow, lung, inguinal LN, and mesenteric LN
in WT and Il17rb
2/2 mice. Numbers indicate percentage of total
mononuclear cells (A) and iNKT cells (B).
(TIF)
Figure S9 Peripheral iNKT cell subtypes in Il15
L117P mice. (A, B)
Number of total iNKT cells (A) and iNKT subtypes based on the
expression of IL-17RB and CD4 (B) in WT B6 and Il15
L117P mice.
Both CD4
2 and CD4
+, IL-17RB
2 iNKT cells in Il15
L117P mice
were dramatically reduced in number among all of the tested
organs.ThemajorityofiNKTcells inliverand BMwere IL-17RB
2
iNKTcells, resultingindecreased cell numbers inIl15
L117P mice. In
contrast, both CD4
2 and CD4
+ IL-17RB
+ iNKT cells in Il15
L117P
mice were present in numbers comparable to WT B6.
(TIF)
Figure S10 Quantitative RT-PCR analysis of iNKT subtypes in
the periphery. (A–D) iNKT cell subtypes from the tissues shown in
Figure 4B were sorted and the same genes were analyzed as in
Figures 3A, 3B, 3D, and 3H. (A) The purity of sorted cells was high
based on the respective level of Cd4 and Il17rb mRNA expression.
Il2rb (=Cd122) expression was restricted to IL-17RB
2 iNKT cells.
(B–D) Expression of TH1/TH2/TH17 related genes (B), cytokine
receptor genes (C), and chemokine receptor genes (D).
(TIF)
Figure S11 Cytokine production by splenic iNKT cell subtypes
from BALB/c mice in vitro. (A–D) Sorted splenic iNKT subtypes
(5610
4 cells/100 mL) were co-cultured with BM-DCs (5610
3/
100 mL) for 48 h in the presence of a-GalCer (100 ng/mL) (A), IL-
12 (10 ng/mL) (B), IL-23 (10 ng/mL) (C), and IL-25 (10 ng/mL)
(D). Levels of IFN-c, IL-4, IL-9, IL-10, IL-13, IL-17A, and IL-22
were analyzed.
(TIF)
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Schematic representation of RSV-G proteins. Membrane form
(Gm, upper) and soluble form (Gs, middle) of RSV-G were shown.
Recombinant RSV-Gs protein (rec Gs) was expressed as a fusion
with a mouse IL-2 leader sequence and a C-terminal tag (BirA-
6His). (B) Western blot analysis of the culture supernatant after
transfection of the rec Gs expression vector into HEK293 cells.
Expressed rec Gs was biotinylated by the BirA enzyme and
detected by stereptavidin-HRP. Rec Gs is a highly glycosylated
mucin-like protein, resulting in a diffuse band in the region of 25–
120 kDa.
(TIF)
Table S1 Primers and probes for quantitative real-time PCR
used in this study.
(DOC)
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